ConductScience.org, home

Paper3000793

Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.

Wellstein A and 3 others. Eur J Clin Pharmacol, 1985. Cited by 75 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man. Papers, record 3000793. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3000793

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
75
iCite
Relative citation ratio, by iCite
4.87
iCite
Revised in PubMed
2019-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wellstein AA
2Palm DD
3Pitschner HFH F
4Belz GGG G

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PropranololMajor topic
Receptors, Adrenergic, betaMajor topic
Adult
Animals
Blood Pressure
Double-Blind Method
Half-Life
Heart Rate
Humans
In Vitro Techniques
Kinetics
Male
Propanolamines
Rats

Source PubMed

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1678,387Pharmacokinetic and pharmacodynamic studies with long-acting propranolol.Br J Clin Pharmacol1978https://conductscience.org/library/papers/678387PubMed
27,000,421The modelling of drug response.Clin Sci (Lond)1980https://conductscience.org/library/papers/7000421PubMed
36,115,730Assessment of beta blockade with propranolol.Clin Pharmacol Ther1981https://conductscience.org/library/papers/6115730PubMed
47,367,746Likely explanation for longer duration of pharmacological (antianginal) effects of propranolol in relation to its short half-life.Res Commun Chem Pathol Pharmacol1980https://conductscience.org/library/papers/7367746PubMed
55,054,588Relation of propranolol plasma level to beta-blockade during oral therapy.Pharmacology1972https://conductscience.org/library/papers/5054588PubMed
62,859,024Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.Arzneimittelforschung1985https://conductscience.org/library/papers/2859024PubMed
76,151,508Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6151508PubMed
86,283,349Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.N Engl J Med1982https://conductscience.org/library/papers/6283349PubMed
96,136,901The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.Mol Pharmacol1983https://conductscience.org/library/papers/6136901PubMed
1013,651,579Some quantitative uses of drug antagonists.Br J Pharmacol Chemother1959https://conductscience.org/library/papers/13651579PubMed
117,431,218Modeling of drug response in individual subjects.J Pharmacokinet Biopharm1980https://conductscience.org/library/papers/7431218PubMed
127,288,596Simultaneous pharmacokinetic and pharmacodynamic modeling.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7288596PubMed
136,139,182Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding.Circ Res1983https://conductscience.org/library/papers/6139182PubMed
146,128,680Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte.Naunyn Schmiedebergs Arch Pharmacol1982https://conductscience.org/library/papers/6128680PubMed
1532,043Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/32043PubMed
166,875,845Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.J Pharmacol Exp Ther1983https://conductscience.org/library/papers/6875845PubMed
174,165,436Effects of atropine on heart-rate in healthy man.Lancet1967https://conductscience.org/library/papers/4165436PubMed
186,102,895Propranolol in the control of blood pressure: a dose-response study.Clin Pharmacol Ther1980https://conductscience.org/library/papers/6102895PubMed
196,319,066Rectal and intravenous propranolol infusion to steady state: kinetics and beta-receptor blockade.Clin Pharmacol Ther1984https://conductscience.org/library/papers/6319066PubMed
206,275,222The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol.Life Sci1981https://conductscience.org/library/papers/6275222PubMed

See all 51 references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.

PMIDTitleJournalYearIn PapersSource
24,372,516Entropic and enthalpic contributions to stereospecific ligand binding from enhanced sampling methods.J Chem Inf Model2014https://conductscience.org/library/papers/24372516PubMed
12,848,769Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.Br J Clin Pharmacol2003https://conductscience.org/library/papers/12848769PubMed
11,994,058The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine.Br J Clin Pharmacol2002https://conductscience.org/library/papers/11994058PubMed
9,663,812Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9663812PubMed
8,656,342Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.J Pharmacokinet Biopharm1995https://conductscience.org/library/papers/8656342PubMed
8,390,369
Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.
Eur J Clin Pharmacol1993https://conductscience.org/library/papers/8390369PubMed
8,099,803Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8099803PubMed
8,070,504Receptor binding assays in analysing the bioavailability and pharmacodynamic bioequivalence of active drug moieties. A study of metoprolol.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/8070504PubMed
7,957,532Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/7957532PubMed
7,912,102Extent of beta 1- and beta 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly.Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/7912102PubMed
7,758,979Plasma kinetics and antagonist activity of topical ocular timolol in elderly patients.Graefes Arch Clin Exp Ophthalmol1995https://conductscience.org/library/papers/7758979PubMed
7,589,027Effects of a Finnish sauna on the pharmacokinetics and haemodynamic actions of propranolol and captopril in healthy volunteers.Eur J Clin Pharmacol1995https://conductscience.org/library/papers/7589027PubMed
3,694,497Pharmacokinetic/pharmacodynamic modeling: what it is!J Pharmacokinet Biopharm1987https://conductscience.org/library/papers/3694497PubMed
3,582,469Pharmacodynamics and pharmacokinetics of urapidil in hypertensive patients: a crossover study comparing infusion with an infusion-capsule combination.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3582469PubMed
3,402,525Pharmacokinetic-pharmacodynamic modelling of oxprenolol in man using continuous non-invasive blood pressure monitoring.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3402525PubMed
3,237,253Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors.Naunyn Schmiedebergs Arch Pharmacol1988https://conductscience.org/library/papers/3237253PubMed
3,185,747Dose-response curves of pirenzepine in man in relation to M1- and M2-cholinoceptor occupancy.Naunyn Schmiedebergs Arch Pharmacol1988https://conductscience.org/library/papers/3185747PubMed
3,028,816Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3028816PubMed
3,000,796Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3000796PubMed
2,974,715Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.Br J Clin Pharmacol1988https://conductscience.org/library/papers/2974715PubMed

See all 30 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3000793

GET https://conductscience.org/api/papers/v1/3000793/references?page=2